fda compounding semaglutide update The has received reports of adverse events after patients used compounded versions of semaglutide. Some compounders may also be using unapproved salt forms. Patients should avoid compounded when an FDA-approved altRx GLP-1 Review 2026: Updated

Reconstitution and preparation for compounded versions Brand-name medications come in pre-filled pens ready to inject

Results may depend on lifestyle factors like diet and physical activity

Lab Testing: What Gets Measured and Why It Matters Found does not routinely require labs, but providers may order them if your health history raises concerns

Wharton S, Batterham RL, Bhatta M, et al

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease

You are comfortable with weekly self-injection and understand the long-term commitment involved